Related Experiment Video
Updated: Jul 9, 2026

Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
Published on: December 4, 2016
Hormesis in precautionary regulatory culture: models preferences and the advancement of science
1CEO HAN, Zoetermeer. hjaap@xs4all.nl
Abstract:
The article focuses on flaws in the actual approaches of exposure to a chemical of recipient organisms. It demonstrates the excessive use of arguments based on adverse effects and underlines the necessity to take adaptive effects seriously. Regulators are invited to rethink their inclination to the 'When in doubt, keep it out.' precautionary approach, with results in counter-productive and costly regulations. The authors are clear about the necessity to include hormesis, in the form of a toxicological insignificant exposure (TIE) level, related to the concentration, as a regulatory translation of adaptive effects. This inclusion might well be the 'brake' for the looming 'collision' with reality of the actual linear toxicological models. This analysis includes the advice to EPA, not to follow the 'witch hunt of synthetic chemicals' as embodied in the EU REACH program.
Related Concept Videos
Drug Regulation
Global Regulatory Systems
Drug Control Governance: Regulatory Bodies and Their Impact
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Other Stress Responses in Bacteria
